Showing results (181-190 of 328) with videos related to
Sort By:
Pageof 33
Endocrine Regulations|July 20, 2012
Molecular and hereditary mechanisms of sensorineural hearing loss with focus on selected endocrinopathiesI Masindova, L Varga, J Stanik, et al.Cancer Letters|January 13, 2010
GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitroSzabolcs Bellyei, Andrew V Schally, Marta Zarandi, et al.Orvosi Hetilap|November 26, 1989
[Has Campylobacter pylori infection any clinical relevance? Methodologic, epidemiologic and clinical studies]Z Döbrönte, F Lakatos, F Brittig, et al.Allergy|December 24, 1997
The severity of clinical symptoms in ragweed-allergic patients is related to the extent of ragweed-induced complement activation in their seraZ Gönczi, L Varga, T Hidvégi, et al.Proceedings of the National Academy of Sciences of the United States of America|August 30, 2000
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormoneG Halmos, A V Schally, J L Varga, et al.Proceedings of the National Academy of Sciences of the United States of America|February 3, 2000
Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitroZ Rekasi, J L Varga, A V Schally, et al.International Journal of Cancer|September 24, 2004
Suppression of growth of H-69 small cell lung carcinoma by antagonists of growth hormone releasing hormone and bombesin is associated with an inhibition of protein kinase C signalingCelia A Kanashiro, Andrew V Schally, Marta Zarandi, et al.Biorxiv : the Preprint Server for Biology|April 10, 2026
Hippocampal representations of temporal structure increase in scale and symmetry across developmentOwen W Friend, Anthony M Dutcher, Nicole L Varga, et al.International Journal of Cancer|March 29, 2002
Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activityArtur Plonowski, Jozsef L Varga, Andrew V Schally, et al.The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancerGabor Halmos, Andrew V Schally, Tamas Czompoly, et al.Pageof 33